发明公开
EP1250600A2 DIAGNOSIS OF TAUOPATHIES DETERMINING TAU/PHOSPHO-TAU RATIO 有权
tau蛋白病通过确定TAU /磷酸-τ的比例诊断

  • 专利标题: DIAGNOSIS OF TAUOPATHIES DETERMINING TAU/PHOSPHO-TAU RATIO
  • 专利标题(中): tau蛋白病通过确定TAU /磷酸-τ的比例诊断
  • 申请号: EP01909655.1
    申请日: 2001-01-18
  • 公开(公告)号: EP1250600A2
    公开(公告)日: 2002-10-23
  • 发明人: VANMECHELEN, EugeenVANDERSTICHELE, Hugo
  • 申请人: INNOGENETICS N.V.
  • 申请人地址: Industriepark Zwijnaarde 7,Box 4 9052 Gent BE
  • 专利权人: INNOGENETICS N.V.
  • 当前专利权人: INNOGENETICS N.V.
  • 当前专利权人地址: Industriepark Zwijnaarde 7,Box 4 9052 Gent BE
  • 优先权: EP00870008 20000124; US178391P 20000127; EP00870280 20001122
  • 国际公布: WO01055725 20010802
  • 主分类号: G01N33/68
  • IPC分类号: G01N33/68 A61K38/17 C07K14/47
DIAGNOSIS OF TAUOPATHIES DETERMINING TAU/PHOSPHO-TAU RATIO
摘要:
The present invention provides a method for the diagnosis of tauopathies in an individual and/or for the differential diagnosis of a tauopathy versus a non-tauopathy based on the detection of the ratio of phospho-tau (181)/ total tau in said individual. The present invention further provides a phospho-peptide for standardization in a method of the invention.
公开/授权文献
信息查询
0/0